BSL — Raffles Medical Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeMid CapHigh Flyer

Annual income statement for Raffles Medical, fiscal year end - December 31st, SGD millions except per share, conversion factor applied.

	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	724	823	707	752	765
Cost of Revenue
Gross Profit	581	731	616	653	664
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	602	627	591	669	675
Operating Profit	121	195	116	82.5	90.4
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	116	191	119	87	93.6
Provision for Income Taxes
Net Income After Taxes	83.7	143	91.1	62.3	71.1
Minority Interest
Net Income Before Extraordinary Items
Net Income	84.2	143	90.2	62.2	70.6
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	84.2	143	90.2	62.2	70.6
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.044	0.082	0.045	0.035	0.039
Dividends per Share
Special Dividends per Share